Quanterix

Quanterix Q1 Revenues up 9 Percent

In Brief This Week: Mayo Clinic, Biocartis, Quanterix, Bluejay Diagnostics, Co-Diagnostics, More

Quanterix Q4 Revenues Rise 16 Percent

Quanterix Projects Q4 2021 Revenues of $29M to $31M

Quanterix Q3 Revenues Decline 12 Percent, Beat Wall Street Estimates

In Brief This Week: Quanterix, Cue Health, Hologic, CareDx, and More

Quanterix Revenues Almost Double in Q2

Quanterix Q1 Revenues up 73 Percent

Quanterix Q4 Revenues Up 64 Percent

In Brief This Week: Roche, Quanterix, Ortho Clinical Diagnostics, Veracyte, and More

Quanterix Prices $250M Public Stock Offering

JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

Quanterix Provides Preliminary Results Projecting Q4 Revenues of $24M to $26M

Quanterix Coronavirus Antigen Test Gets FDA Emergency Use Authorization

Quanterix Gets FDA EUA for SARS-CoV-2 Antibody Test

Quanterix Q3 Revenues Increase 111 Percent on License, Grant Revenue

Quanterix Continues to Use Partnerships to Drive Clinical Strategy

RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing